Weekly Roundup -
April 22, 2026
Smart. Strategic. Essential.
Unmatched Healthcare Insights from 量子资源网,
Leavitt Partners & Wakely.
Featured:
Medicare鈥檚 “Inpatient Only” Rule Is Going Away. Now What?
LISTEN NOWTrending: In Focus
量子资源网 Resource Provides Key Insights about the Evolving Medicare-Medicaid Integration Landscape
People who are听dually eligible听蹿or听Medicare and Medicaid听remain听a central focus听蹿or policymakers and healthcare organizations,听given听their complex care needs, disproportionate share of spending, and听the long-standing听challenge of coordinating coverage across two programs. One of the primary vehicles for advancing integration has been听Dual Eligible Special Needs Plans (D-SNPs), which听continue to play an increasingly prominent role as federal and state policymakers听encourage tighter Medicare-Medicaid alignment.
As听states听play听a more active听role in shaping enrollment rules, Medicaid contracting, and procurement strategies, the duals market is becoming more structured and more explicitly guided by state听policy decisions.听量子资源网听(贬惭础鈥檚)听2026听Duals Integration Environmental Inventory,听examines听how听this shift听shapes the integration landscape听in 2026.听This听comprehensive inventory听is听based on听a听review of the 2026 market, insights from states, and other publicly available resources.
This article听examines key trends from 贬惭础鈥檚听2026听inventory听and听addresses听蹿ederal policy听changes听scheduled to take听effect听蹿or 2027,听which听contribute to听this dynamic听environment.
What to Expect in 2026
As the landscape for duals integration evolves, the central question has shifted from whether D-SNPs operate in a state to the more consequential question of how states are using Medicaid policy levers (i.e., enrollment rules, procurement, contracting, and managed care structures) to drive tighter alignment between Medicare and Medicaid.听
At the federal level, recent Medicare Advantage and Part D rulemaking is reinforcing that听movement.听The听 finalized the second phase-down of the D-SNP look-alike threshold to 60 percent for 2026 and established 2027 rules that limit enrollment in certain D-SNPs to members of an affiliated Medicaid managed care organization. The rule also limits the number of D-SNP benefit packages that can be offered alongside an affiliated Medicaid managed care organization. More recently, the 听requires听certain D-SNPs to use integrated member ID cards and integrated health risk assessments beginning in 2027.听
Together these rules signal a continued federal emphasis on听linking听D-SNP enrollment and operations听more closely to Medicaid coverage and听delivery systems, with states playing a听greater听role in听determining听how alignment is achieved.听
What the 2026 Inventory Shows
贬惭础鈥檚 2026 Duals Integration Environmental Inventory shows how these policy signals are translating into state action. More specifically:听
- Statewide exclusively aligned enrollment appears in 16 states in the 2026 inventory, up from听nine听in 2025.听
- Applicable Integrated Plans (AIPs) are present in 22 states, up from 14, and default enrollment is in place in 21 states, up from 16.听
- The inventory also captures 6,084,997 total D-SNP enrollees, including 1,975,250 in听Highly Integrated听SNPs听(HIDE)听and 743,683 in听Fully Integrated SNPs (FIDE-SNPs).听
Those changes are already visible in state markets:听
- Illinois, Massachusetts, Ohio, and Rhode Island entered听2026 with a greater FIDE-SNP presence tied to legacy Medicare-Medicaid Plan transitions.听
- Michigan听launched听MI Coordinated Health as a HIDE-SNP in selected regions in 2026, with statewide expansion planned for 2027.听
- Delaware also stands out:听Although it already had AIPs in the 2025 inventory, it adds statewide exclusively aligned enrollment in 2026 and shows both HIDE-SNPs and coordination-only D-SNPs.听
A Resource to Track State Market Direction
贬惭础鈥檚 , available听to听量子资源网 Information Services听(量子资源网IS)听subscribers,听includes听a state-by-state view of the Medicaid policy, contracting, and program structures shaping听duals听integration and D-SNP markets. In addition to听enrollment听trends, the inventory documents the integration model each state is pursuing, whether long-term services and supports or behavioral health听are included in managed care, and how procurement and contract decisions may inform future market activity.听
量子资源网 experts work with clients to听apply听this information听and听deepen their understanding of state听integration听approaches, inform assessments of their market readiness and alignment opportunities, and develop strategies that support more effective听Medicare-Medicaid integration.听
Looking Ahead
Notably, 贬惭础鈥檚 inventory reflects a point in time understanding of where an individual state is today and what is known at this time about their next steps and plans. However, we expect changes in many states as they seek guidance from the Centers for Medicare & Medicaid Services and the D-SNP community to implement required changes and adopt new regulatory provisions that support state goals and priorities.听
The 2026 inventory suggests that听more states are using formal alignment听tools,听that听more enrollment is concentrated in integrated products, and听that听more markets are being shaped by the interaction between Medicaid structure, procurement, and D-SNP strategy.听
Connect with Us听
For organizations听seeking听to understand where the market is headed,听the听Duals Integration Inventory offers a clear view of how state policy and market structure are evolving and where tighter Medicare-Medicaid alignment is taking hold.听
Contact听Holly Michaels Fisher听and听Julie Faulhaber听to听discuss your听organization鈥檚听questions and needs听regarding听an听integration听strategy and听market听analysis. For information about the 量子资源网IS subscription,听access to the Duals Environmental Inventory contact听Andrea Maresca听and听Gabby Palmieri.听
Medicaid Managed Care Enrollment: Q4 2025 Trends and Early Signals Ahead of New Eligibility Policies
This week听量子资源网 (量子资源网),听draws on its database of monthly Medicaid managed care听enrollment听to听present its听latest quarterly analysis, offering a snapshot of听enrollment trends听across 37 states.听
The analysis comes at a critical听time. As states prepare for Medicaid eligibility policy changes听that take effect in 2027鈥攊ncluding听more frequent eligibility determinations and听expanded work and community engagement requirements鈥攃urrent enrollment trends provide an early signal of how policy decisions and administrative practices are already influencing coverage听levels.听
The 量子资源网 Information Services (量子资源网IS) analysis shows that听Medicaid managed care accounted for 85.6听percent听of total Medicaid enrollment in December 2025.听This analysis, available to听量子资源网IS听subscribers, uses听data from听nearly 300听health plans in 41 states.鈥疶he report provides by-plan enrollment plus corporate ownership, program inclusion, and for-profit versus not-for-profit status, with breakout tabs for publicly traded plans.听
Key Insights from Q4听2025 Data听
The听37听states included in听this听review have released monthly Medicaid managed care enrollment data听through听public websites听or in response to a public records request听蹿rom听量子资源网.听The report includes听the most recent data听obtained and illustrates the听effect of state-level choices around eligibility and administration. Key findings include:听
- As of听December听2025,听Medicaid managed care enrollment across the 37 states declined by听2.2 million members听year over year, falling to 62.5 million鈥攁听3.4 percent decrease.听
- Of the 37 states,听eight鈥擟olorado, Delaware, Mississippi, Missouri, New Jersey, North Carolina, North Dakota, and Oregon鈥攄id听not听experience year-over-year听managed care enrollment听declines,听and听instead showed听蹿lat enrollment or modest gains.听With the exception of Mississippi, these听are听all听Medicaid expansion states.听
- Arizona听and Indiana听experienced听double-digit听percentage听declines. Notably,听Indiana began requiring听enrollees听to actively respond to renewal mailers,听which aligns with听enrollment declines that began in March 2025.听
- Among the听expansion states in the analysis,听enrollment听declined听by听1.7听million (-3.3%) to听50.8听million.听The听seven non-expansion states听experienced听a听similar听decline (-3.6%),听bringing听enrollment to听11.7听million enrollees.听
Data Considerations.听The data听have听some听important limitations.听States report听enrollment figures at different points听during听the听month,听with听some data听reflecting听beginning of the month totals听and听others capturing听end of the month听enrollment.听In addition,听some听state datasets encompass all Medicaid programs offering managed care听plans,听whereas听others听reflect only a subset of the managed Medicaid population.听As a result, the听蹿indings should be听viewed as听indicative of broader trends rather than听a comprehensive听state-by-state comparison.鈥听
Market Share and Plan Dynamics听
Using our data repository听蹿or听300 health plans across 41 states, 量子资源网IS听analyzes听corporate ownership, program participation, and tax status听among Medicaid managed care plans. As of听December听2025, Centene听maintained the largest share of the national听Medicaid managed care market听at听17.8听percent,听蹿ollowed by Elevance (10.4%), United (8.5%), and Molina (6.0%)听(see听Figure听1).鈥These figures highlight continued concentration among large national plans, even as overall enrollment declines.听
Figure 1. National Medicaid Managed Care Market Share by Number of Beneficiaries for a Sample of Publicly Traded Plans,听December听2025鈥听
What to Watch鈥
Enrollment trends听observed听in听the fourth quarter听(Q4)听of听2025听and continuing into听2026听indicate听increasing state attention to eligibility policy and program integrity.听State legislative activity,听budget pressures, and federal听regulatory developments听are prompting many states to听assess and strengthen certain aspects of their programs听related to听eligibility, particularly as听they听prepare to implement redetermination and work and community engagement requirements.听
Several states are already moving toward implementation. Nebraska is scheduled to launch Medicaid work requirements on May 1,听2026,听while Montana plans to begin implementation on July 1, 2026.听With听additional听蹿ederal guidance still听emerging, most other states are working toward compliance ahead of January 2027 deadlines.听In听expansion听states,听policymakers听retain听authority to tighten administrative processes, alter optional benefits, or adjust provider payment levels鈥攁ctions that听may听materially affect enrollment.听
These听developments underscore why Medicaid managed care enrollment trends听deserve听close attention. Declines in enrollment are often an early indicator of broader system impacts, including rising uncompensated care for providers, shifts in payer mix, and increased financial pressure on听safety鈥net听systems. For managed care organizations, even modest enrollment changes can mask more significant shifts in risk profiles, geographic concentration, or service needs.听
Connect with Us鈥
量子资源网 is home to experts who know the Medicaid managed care landscape听and how it is evolving.听量子资源网IS鈥檚听Medicaid听enrollment data, financials,听procurement听tracking, and a robust library of public documents鈥equips stakeholders with听timely, actionable intelligence.听
For more information about the 量子资源网IS subscription, contact鈥Andrea Maresca鈥痑苍诲鈥Alona Nenko.鈥听
CMS Proposes Modest Hospital Payment Updates and Signals Expanded Use of Mandatory Value-Based Models
On April 10, 2026, the Centers for Medicare & Medicaid Services (CMS) released the proposed rule for the听. The proposal combines a modest net increase in hospital payments with policy signals around quality reporting and mandatory episode-based payment models鈥攎ost notably a proposed nationwide expansion of the Comprehensive Care for Joint Replacement (CJR) model.听
These听proposed updates underscore CMS鈥檚听continued emphasis on value-based purchasing, episode accountability, and alignment across quality programs. In addition, CMS resurfaces听ongoing听debates听with hospital stakeholders about the adequacy of Medicare payment updates amid rising costs and coverage disruptions.听
This article reviews several key provisions听in the听FY 2027听proposed听rule.听
Hospital Payment Updates: Headline Increase Masks Net Impact听
Under the proposed rule, CMS would increase base IPPS and LTCH PPS payment rates by 2.4 percent听in听FY 2027. However, after accounting for proposed reductions to uncompensated care payments for disproportionate share hospitals听(DSH)听and changes听in听outlier payments for extraordinarily high-cost cases, CMS estimates the effective payment increase would be closer to 1.2 percent.听
In aggregate, CMS听projects听the proposed update would translate to approximately听$1.4 billion听in听additional听payments to acute care hospitals next year. Hospital industry groups鈥攊ncluding the American Hospital Association (AHA) and the Federation of American Hospitals (FAH)鈥攈ave pushed back, arguing that the proposed update does not sufficiently reflect medical inflation, workforce pressures, or听anticipated听growth in the uninsured population.听
These concerns听reflect听a听long-standing听dynamic in annual hospital payment rules: CMS听seeking听to听balance听statutory updates and budget neutrality constraints against听the hospital听industry鈥檚 concern听that Medicare payments are听lagging听behind听underlying costs.听
Quality Reporting and Program Alignment听
The proposed rule would also make notable updates to the Hospital Inpatient Quality Reporting (IQR) Program. CMS proposes听adding听three new quality measures to be phased in during 2029 and 2030, while听modifying听eight existing measures to include Medicare Advantage patients. CMS also proposes shortening the performance period for certain measures from three years to two鈥攁听change designed to accelerate feedback and better align measures across programs.听
These changes continue CMS鈥檚听broader effort to harmonize quality measurement across Medicare payment and value-based programs, reduce reporting lag, and incorporate a more comprehensive view of patient populations.听
Updates to听Mandatory听TEAM听Model听
CMS also proposes several updates to the Transforming Episode Accountability Model (TEAM), the mandatory episode-based payment model听蹿inalized听last year. Key proposals include:听
- Expanding the list of听MS-DRGs听included in the spinal fusion episode听
- Aligning TEAM quality measurement performance periods with the IQR Program听
- Making targeted technical refinements to payment听methodology听
In addition, CMS is seeking stakeholder feedback on whether ambulatory surgery centers (ASCs) should听participate听in TEAM and whether participation should be voluntary for physician-owned hospitals,听signaling potential future expansion or recalibration of the model.听
Proposed Expansion of Joint Replacement Bundles听
CMS听proposes to听expand the existing听Comprehensive Care for Joint Replacement Expanded (CJR-X) Model听nationwide听beginning October 1, 2027.听The agency also plans to听make participation mandatory for most IPPS hospitals.听
CMS tested the original CJR model in 34 metropolitan areas between 2016 and 2024, generating听improved patient outcomes and net Medicare savings, according to听agency听evaluations. CJR-X听would听become the fifth Center for Medicare and Medicaid Innovation model to meet the statutory criteria for nationwide expansion.听
Under CJR-X, hospitals performing lower extremity joint replacements would be听accountable for the cost and quality of care for the听initial听procedure and most related spending during the听subsequent听90 days.听Although听the overall structure mirrors the original CJR model, CMS proposes several important updates:听
- Expansion of episodes to include ankle replacements, in addition to hip and knee procedures听
- Adoption of a more robust risk adjustment听methodology听with significantly more variables, aligning closely with the TEAM model听
- Introduction of a 5 percent stop-loss policy for hospitals听that听serve听higher proportions of dually eligible beneficiaries and certain smaller hospitals听
Participation would be mandatory for most IPPS hospitals, with exceptions for hospitals already听participating听in TEAM,听which includes a lower extremity joint replacement episode;听Maryland hospitals听operating听under global budgets;听and hospitals not paid under both IPPS and the Outpatient Prospective Payment System,听such as Critical Access Hospitals.听
Why It Matters听
The 2027 IPPS and LTCH PPS proposed rule reinforces several clear policy signals:听
- Pressure on hospital margins is likely to persist, as payment updates continue to trail hospital-reported cost growth.听
- Mandatory episode-based models听remain听central to CMS鈥檚听value-based strategy, with CJR-X听representing听a significant escalation in scope and scale.听
- Program alignment and MA inclusion are accelerating, with implications for hospital data systems, care coordination strategies, and reporting infrastructure.听
Hospitals and health systems will need to assess not only the near-term听蹿inancial impact听of the proposed payment updates, but also their readiness听to accept听expanded episode accountability and听meet听evolving quality measurement requirements.听
Comments on the proposed rule will shape final decisions听regarding听payment levels, quality program changes, and the scope of mandatory participation in CJR-X. Stakeholders will be watching closely to see whether CMS moderates its approach to mandatory models or doubles down on episode-based accountability as a cornerstone of Medicare payment reform.听
In parallel, CMS has released several other proposed听payment听rules this month,听including听those that听would affect听skilled nursing facilities, hospice providers, inpatient rehabilitation facilities, and inpatient psychiatric facilities. For these entities, CMS听generally proposes听payment updates of approximately 2.4 percent听and听2.3 percent for inpatient psychiatric facilities. As part of its broader听program听integrity focus, CMS also听has听proposed new transparency measures for hospice providers; this听蹿ollows听recent enforcement actions related to fraudulent enrollment.听
Connect with Us听
量子资源网, Inc.听(量子资源网),听monitors听蹿ederal regulatory and legislative developments in the inpatient setting and assesses the impact on hospitals, life science companies, and other stakeholders.听Our experts interpret and model hospital payment policies and assist clients in developing CMS comment letters and long-term strategic plans.听Our team replicates CMS payment methodologies and model alternative policies using the most听recent听Medicare fee-for-service and Medicare Advantage (100%) claims data. We also support clients with DRG reassignment requests,听New Technology Add-on Payment (NTAP)听applications, and analyses of Innovation Center alternative payment models.听
For more information about the proposed policies, contact听one of听our听Medicare听experts.听
Federal Policy News
Fueled By Weekly Health Intelligence
Leadership Shift at HHS Signals New Direction for Public Health and Affordability
A number of recent announcements signaled further leadership changes at听the US Department of Health and Human Services (HHS), notable among them President Trump鈥檚 announcement on April 16 through a听听that he is nominating Erica Schwartz, MD, JD, MPH, to serve as the new听Centers for Disease Control and Prevention (CDC)听Director.听The agency has been without a confirmed director since Dr. Susan Monarez鈥檚 departure in August 2025, with former HHS Deputy Secretary Jim O鈥橬eill followed by NIH Director Dr. Jay Bhattacharya temporarily leading the agency since then. Dr. Schwartz is a retired Rear Admiral in the U.S. Public Health Service Commissioned Corps and served as Deputy听US听Surgeon General from January 2019 to April 2021, during President Trump鈥檚 first term and at the height of the COVID-19 pandemic. HHS Secretary Robert F. Kennedy, Jr. also expressed his听听蹿or the nomination last week.听听
Further, Dr. Schwartz鈥檚 nomination has been听largely positively听received by public health leaders, including the听听and Dr. Jerome Adams, a former US Surgeon General, who has been a vocal critic of the current Trump Administration鈥檚 changes to public health policy.听听
Dr. Schwartz鈥檚 nomination will be considered by the Senate HELP Committee.听
In the post announcing Dr. Schwartz鈥檚 nomination, President Trump also announced the appointment of Mr. Sean Slovenski, a healthcare executive, as CDC Deputy Director and Chief Operating Officer; Dr. Jennifer Shuford, the Commissioner of the Texas Department of State Health Services, as CDC Deputy Director and Chief Medical Officer; and Dr. Sara Brenner, the Principal Deputy Commissioner of FDA as Senior Counselor for Public Health to Secretary Kennedy.听
Further, on April 17, Secretary Kennedy听听that economist Casey B. Mulligan, PhD, will serve as the Chief Economist and Chief Regulatory Officer of HHS. Dr. Mulligan previously served as Chief Economist on the Council of Economic Advisers during the first Trump Administration and the Chief Counsel for Advocacy at the US Small Business Administration. In the press release announcing the appointment, HHS states that 鈥渉is portfolio will include cost-benefit analysis of regulation, econometric modeling, and program evaluation of major expenditures,鈥 with a focus on making healthcare more affordable.听
The personnel changes at HHS听likely reflect听a waning interest among White House personnel to place MAHA-affiliated leaders in senior departmental positions, particularly as the nomination of Casey Means to be Surgeon General has stalled and the midterm elections approach. The personnel announcements听are instead听intended to reflect a disciplined message from the Administration and a focus on healthcare affordability.听
Executive Order Advances Psychedelic Therapy Research
On April 18, President Trump听听an Executive Order (EO), titled, 鈥淎ccelerating Medical Treatments for Serious Mental Illness.鈥听The EO discusses the prevalence and severity of serious mental illness in the United States, particularly among U.S. veterans, as well as suicide rates. The EO notes the complex nature of treating these conditions, including that they are often resistant to treatment, and goes on to discuss the potential use of psychedelic drugs to treat these conditions, 鈥渇or patients whose conditions persist after completing standard therapy.鈥 As such, the EO:听
- Directs FDA to 鈥減rovide Commissioner鈥檚 National Priority Vouchers to appropriate psychedelic drugs that have received a Breakthrough Therapy designation and are in accordance with the criteria of the National Priority Voucher Program.鈥 The CNPV provides faster review times and increased communication with the agency for sponsors of drug and biologics applications that support administration priorities.听
- Directs FDA to听establish听a pathway for eligible patients to access psychedelic drugs consistent with the Right to Try Act.听
- Directs HHS through ARPA-H to听allocate听$50 million in existing funds to a federal and state government collaboration focused on supporting states that have 鈥渆nacted or are developing programs to advance psychedelic drugs for serious mental illnesses鈥 through technical听assistance听and data sharing. In the听听detailing the EO provisions, it is听stated听that this funding should be used to 鈥渢o match investments made by state governments.鈥濃听
- Directs HHS, FDA, and the VA to collaborate to 鈥渋ncrease clinical trial participation, data sharing, and real-world evidence generation鈥澨齬egarding听the use of psychedelic drugs. Specifically, the EO directs the agencies to enter data-sharing agreements such that FDA may access relevant data that would听ultimately support听drug approvals.听
- Directs the Attorney General to 鈥渋nitiate and complete review of any product containing a Schedule I substance that has successfully completed Phase 3 clinical trials for a serious mental health disorder,鈥 to ensure听timely听rescheduling of the drug if听appropriate.听
FDA Steps Up Efforts to Close Gaps in Clinical Trial Reporting
On April 13,听the US Food and Drug Administration (FDA)听听that it sent messages to more than 2,200 medical product companies and researchers to remined them of requirements to听disclose听certain clinical trial results information to ClinicalTrials.gov. The听, section 801 and听subsequent听听requires sponsors to register and听submit听summary results within one year after completing a clinical trial of an FDA-regulated drug, biological product, or medical device regardless of听whether or not听the results are favorable.听听
On March 30, the agency contacted sponsors and researchers associated with more than 3,000 registered clinical trials that do not appear to have听submitted听required results information or potentially incomplete actions related to the听听quality control review process. FDA听stated听that, of those studies highly likely to be subject to such requirements, an internal estimate of 29.6 percent of studies do not have results data听submitted听to ClinicalTrials.gov. The messages seek voluntary compliance and represent an 鈥渆xtra step鈥 the agency is taking before considering further action, which may include听听and听. FDA framed the initiative as a means of reducing publication bias, improving patient safety, and better informing clinicians and researchers about the benefits and risks of medical products.听
HHS Budget Hearings Continue; House Advances Healthcare Bills
After听appearing before three House committees last week,听HHS听Secretary Robert F. Kennedy, Jr. returns to the Hill this week to testify on the听. This past week he testified before the House Ways and Means Committee, Education and Workforce Committee, and Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, where members asked questions related to the Administrations expenditure of FY 2026 funding, and the proposed budget for FY 2027. Several听committee members reiterated concerns听regarding听the Administration鈥檚 policy changes related to vaccines, biomedical research, and HHS staffing, while Republican Committee members and some Democrats applauded actions related to addressing the prevalence of artificial food dyes and microplastics in the environment. Secretary Kennedy highlighted recent action taken by the Administration to advance the MAHA agenda, while previewing future action including reforming the U.S. Preventive Services Task Force.鈥听
Further, this week, the House听听the following healthcare legislation under suspension of the rules:听
- , the Women and Lung Cancer Research and Preventive Services Act of 2025, which requires the Secretary of HHS, in consultation with the Secretaries of Defense and Veterans Affairs, to conduct an interagency review and make recommendations on opportunities related to accelerating research related to lung cancer in women and underserved populations, access to lung cancer screenings for those populations, and lung cancer public awareness and education campaigns.听听
- , the Improving Care in Rural America Reauthorization Act of 2025, which would reauthorize certain rural health grants and update uses of funds for rural underserved populations. The bill extends the following programs at currently authorized levels of $79.5 million for each of fiscal years 2026 through 2030:听听
- Rural Health Care Services Outreach Grants;听
- Rural Health Network Development Grants; and听
- Small Health Care Provider Quality Improvement Grants.听
- , the Telehealth Network and Telehealth Resource Centers Grant Program Reauthorization Act, which would reauthorize the grant programs at $42 million for听each of听蹿iscal听years听2026 through 2030.听
Each of these bills was reported out of the House Energy and Commerce Committee with unanimous support and are expected to easily pass in the House. Two of the bills, the Improving Care in Rural America Reauthorization Act and the Women and Lung Cancer Research and Preventive Services Act, have companion legislation introduced in the Senate that have been reported out of the Senate HELP Committee.听
Ready to talk about your organization's challenges?
Schedule a ConsultationState Policy News
Hawaii Awards AlohaCare Medicaid Behavioral CCS Contract
Hawaii鈥檚 Department of Human Services, Med-QUEST Division,鈥鈥痮n April 8, 2026, that it awarded听AlohaCare听a competitive contract to operate the Community Care Services (CCS) program, which provides comprehensive behavioral health services integrated with physical health services to Medicaid-enrolled adults with serious mental illness or serious and persistent mental illness. The program is delivered statewide and is intended to听provide听the full range of required behavioral health services under the request for proposals. The contract carries a total value of $180 million, with a contract period running from July 1, 2026, through June 30, 2029. The incumbent is Centene/Ohana Health Plan.听
Kentucky Launches Medicaid Reentry Coverage for Individuals Leaving Incarceration
The Kentucky Lantern鈥鈥痮n April 16, 2026, that it is implementing a federal 1115 reentry demonstration that will provide eligible people leaving incarceration with Medicaid coverage for 12 months and a one-month supply of prescribed medications upon release. The program allows pre-release screenings beginning听60 days听before scheduled release and is intended to support reentry, reduce recidivism and overdose deaths, and improve access to care. While the demonstration was approved in 2024, state officials said implementation took time because it听required听coordination across agencies, eligibility systems, and听correctional facilities.听
Michigan Awards Healthy Kids Dental Contract to Delta Dental
The Michigan Department of Health and Human Services (MDHHS)鈥鈥痮n April 17, 2026, that it听is awarding the Healthy Kids Dental contract to incumbent Delta Dental. The program serves approximately听955,000 children听under the age of 21, and covers services such as X-rays, cleanings, fillings, extractions, and sealants. The new contract will begin October 1, 2026, and run through September 30, 2031, with up to three one-year extension options.听
Minnesota Warns $3.1 Billion in Federal Medicaid Funding Remains at Risk
Minnesota Department of Human Services鈥鈥痮n April 16, 2026, that state officials warned that despite federal approval of the state鈥檚 corrective action plan, up to听$3.1 billion听in Medicaid funding听remains听at risk as the Centers for Medicare & Medicaid Services continues to defer and withhold payments. State officials said the ongoing funding restrictions could destabilize healthcare providers and local economies, particularly in rural areas. The state is听appealing听the federal actions while continuing to听implement fraud prevention measures, including provider revalidation, enhanced payment review, provider dis-enrollments, and other program integrity initiatives.听
Pennsylvania Court Rules Medicaid Abortion Ban Unconstitutional
WGAL鈥鈥痮n April 20, 2026,听that听the Pennsylvania Commonwealth Court declared that the state鈥檚 ban on Medicaid-covered abortions is unconstitutional in a 4-3 ruling. The judges听determined听that the state constitution includes the fundamental right to reproductive autonomy,听rendering听the ban unconstitutional.听
Virginia Seeks to Develop Medicaid Maternal Health Desert Mobile Clinic Pilot Program
The Virginia Department of Medical Assistance Services (DMAS)鈥鈥痮n April 17, 2026, a request for information (RFI) on the development and implementation of a Maternal Health Desert Mobile Clinic Pilot Program, which would expand access to prenatal and postpartum care for Medicaid and CHIP members in underserved areas. DMAS is seeking information听regarding听organizational experience, service delivery models, geographic coverage, partnerships, outreach, data collection, and reporting practices from organizations with听expertise听in mobile health service delivery, maternal health, and care coordination. Responses are due May 1, 2026.听
Private Market News
Fueled By
California Judge Tosses Elevance鈥檚 Surprise Billing Suit
A an Elevance Health lawsuit accusing听HaloMD听and providers of abusing the No Surprises Act鈥檚 dispute听process,听ruling the insurer听failed to听prove wrongdoing. The decision is a win for providers and may limit insurers鈥 ability to challenge payment disputes in court, though Elevance plans to appeal.听
Medicare Navigation Company Chapter Secures New Round of Funding
听secured a $100 million Series E led by Generation Investment听Management, and听听it more than doubled its valuation since its last raise less than a year ago. The company reported that听its听revenue tripled in 2025 as it surpassed $100 million in annual recurring revenue.听听
Studies Examine General Purpose Chatbots
Two听new studies听highlight significant limitations in general-purpose artificial intelligence chatbots used for health–related questions. One听听蹿inds that, across 21 off-the-shelf large language models and 29 standardized clinical vignettes, differential-diagnosis failure rates exceeded 80听percent听蹿or every model. The findings suggest general-purpose chatbots remain unreliable for听initial听diagnostic reasoning, even if performance improves once听additional听clinical information is provided. Another study finds that 50听percent听of responses from five publicly available chatbots to听evidence–based听health questions were听somewhat or听highly problematic, with especially weak performance on open-ended prompts. The findings reinforce ongoing concerns about consumers relying on off-the-shelf chatbots for medical advice without clinician oversight.听
Our Insights
Fueled By Experts Across Our 量子资源网 Companies
量子资源网
Saving Lives with Compassion: Overdose Response Training with RiVive庐
This听webinar听will present findings from the 2025听RiVive Community Engagement Report and best practices in Compassionate Overdose Response鈩, with a focus on the community use of RiVive听naloxone nasal spray 3 mg. A panel of expert speakers will present their protocols for effective overdose intervention, guidance on the training of others, and strategies for integrating trauma-informed approaches into post-overdose care. Designed for program teams, medical professionals, and harm reduction leaders, anyone who attends will leave with research and experience-backed methods for improving outcomes in opioid overdose emergencies. A recording of this听webinar听will be available after this session, with a link to the 2025 report.听
2026 Michigan State of Reform Health Policy Conference | May 5, 2026
The 2026 Michigan State of Reform Health Policy Conference will be taking place in-person on May 5th,听2026听at the Kellogg Hotel and Conference Center!听Managing constant change in healthcare takes more than听just hard听work. It takes a solid understanding of the legislative process and knowledge about听intricacies听of the healthcare system.听That鈥檚听where听State听of Reform comes in.
2026 Maryland State of Reform Health Policy Conference | May 21, 2026
The 2026 Maryland State of Reform Health Policy Conference will be taking place in-person on May 21st, 2026 at the Baltimore Marriott Waterfront! Managing constant change in healthcare takes more than just hard work. It takes a solid understanding of the legislative process and knowledge about intricacies of the healthcare system. That鈥檚 where State of Reform comes in.
RFP Calendar
RFP Calendar
| Date | State/Program | Event | Beneficiaries |
|---|---|---|---|
| Date: February 2026 - DELAYED | State/Program: Illinois | Event: Awards | Beneficiaries: 2,400,000 |
| Date: May 1, 2026 | State/Program: Nevada Children's Specialty | Event: Proposals Due | Beneficiaries: NA |
| Date: May 12, 2026 | State/Program: Nevada CO D-SNP | Event: Awards | Beneficiaries: 88,000 |
| Date: June 24, 2026 | State/Program: Wisconsin LTC GSR 3 | Event: Awards | Beneficiaries: 56,000 (all GSR) |
| Date: Summer 2026 | State/Program: Illinois Foster Care | Event: RFP Release | Beneficiaries: 33,000 |
| Date: July 1, 2026 | State/Program: Hawaii Community Care Services | Event: Implementation | Beneficiaries: 5,500 |
| Date: July 28, 2026 | State/Program: Nevada Children's Specialty | Event: Awards | Beneficiaries: NA |
| Date: August 2026 | State/Program: Indiana | Event: RFP Release | Beneficiaries: 1,400,000 |
| Date: January 1, 2027 | State/Program: Illinois | Event: Implementation | Beneficiaries: 2,400,000 |
| Date: January 1, 2027 | State/Program: Nevada CO D-SNP | Event: Implementation | Beneficiaries: 88,000 |
| Date: January 1, 2027 | State/Program: Wisconsin LTC GSR 3 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: January 1, 2027 | State/Program: Illinois Tailored Care Management Program | Event: Implementation | Beneficiaries: 22,400 |
| Date: July 1, 2027 | State/Program: Nevada Children's Specialty | Event: Implementation | Beneficiaries: NA |
| Date: January 1, 2028 | State/Program: Wisconsin LTC GSR 4,6 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: Fall 2027 | State/Program: Oregon | Event: RFP Release | Beneficiaries: 1,200,000 |
| Date: 2028 | State/Program: North Carolina | Event: RFP Release | Beneficiaries: 2,200,000 |
| Date: 2029 | State/Program: California | Event: RFP Release | Beneficiaries: NA |
